Regencell Bioscience Holdings Ltd Cash Flow Statement

Cash Flow Statement Jun2019 Jun2020 Jun2021 Jun2022 Jun2023 Jun2024 Jun2025
Operating Activities
Net Income -0.39M-0.81M-1.35M-7.59M-6.06M-4.36M-3.58M
Depreciation and Depletion 0.01M0.03M0.15M0.29M0.31M0.08M
Share-based Compensation 0.92M2.76M0.92M0.45M7.79M
Gains from Investment Securities 1.44M0.19M0.07M0.78M
Cash from Operations -0.39M-0.73M-0.77M-5.27M-4.96M-4.00M-3.11M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.45M0.48M0.44M0.32M
Depreciation & Amortization (CF) 0.01M0.03M0.15M0.29M0.31M0.08M
Change in Working Capital
Change in Accured Expenses 0.10M0.48M-0.43M-0.49M-0.47M-0.35M
Other Working Capital Changes 0.01M0.01M0.03M0.10M-0.15M
Investing Activities
Capital Expenditures 0.12M0.78M0.03M0.01M0.15M
Sales of Property, Plant and Equipment 970.00
Change in Acquisitions & Divestments 10.09M10.25M35.32M
Cash from Investing Activities -0.12M-10.78M0.06M5.24M2.69M
Financing Activities
Other financing activities 0.17M0.16M0.13M0.10M
Cash from Financing Activities 0.48M0.99M0.44M22.41M0.13M0.10M
Additional items
Exchange Rate Effect -0.08M0.05M-0.11M
Change in Cash 0.09M0.14M-0.33M6.36M-4.85M1.40M-0.54M
Beginning Cash Balance -0.09M-0.14M0.33M-6.36M4.85M-1.40M0.54M
Free Cash Flow -0.39M-0.84M-0.77M-6.05M-4.99M-4.01M-3.27M
Net Cash Flow 0.09M0.14M-0.33M6.36M-4.77M1.34M-0.43M